Pathobiotek gains US patent for "activating virus"
This article was originally published in Clinica
Pathobiotek Diagnostics has been awarded a US patent covering tests for a virus thought to be associated with a number of cancers and immunodeficiency diseases. The "activating virus", which has not yet been fully characterised but is believed to be a herpes virus, was discovered in marmosets with wasting syndrome, a condition that resembles AIDS in humans. Pathobiotek has also been awarded a notice of allowance on a patent covering the Leuy bacterium, which is implicated in the aetiology of multiple sclerosis.